Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data
Pain Ther
.
2023 Jun;12(3):889.
doi: 10.1007/s40122-023-00502-4.
Authors
David Chandler
1
,
Christine Szekely
2
,
Shivani Aggarwal
2
,
Lori Cyprien
2
,
Mark Bensink
3
Affiliations
1
Global Health Economics, Amgen Inc., 1 Amgen Center Dr, Thousand Oaks, CA, 91320, USA. the3chandlers@msn.com.
2
Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA.
3
Global Health Economics, Amgen Inc., 1 Amgen Center Dr, Thousand Oaks, CA, 91320, USA.
PMID:
37014622
PMCID:
PMC10199964
DOI:
10.1007/s40122-023-00502-4
No abstract available
Publication types
Published Erratum